Skip to main content
S. 1323 117th Congress Senate

End Price Gouging for Medications Act

Official title: A bill to require the Secretary of Health and Human Services to establish reference prices for prescription drugs for purposes of Federal health programs, and for other purposes.

Introduced: April 22, 2021 Introduced by: Jeff Merkley Democratic · Oregon See on congress.gov
Health AsiaAustraliaCanadaCivil actions and liability
More subjectsShow fewer subjects
EuropeFranceGermanyHealth care costs and insuranceHealth care coverage and accessInflation and pricesItalyJapanMedicaidMedical researchMedicareMilitary medicineNetherlandsNorth AmericaOceaniaPrescription drugsRetail and wholesale tradesSpainSwedenSwitzerlandUnited KingdomVeterans' medical care
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 22, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Apr 22, 2021
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action April 22, 2021

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Plain-English summary Congressional Research Service

End Price Gouging for Medications Act

This bill requires the Department of Health and Human Services (HHS) to set maximum prices for prescription drugs under specified federal health programs. Specifically, HHS must establish reference prices based on certain factors, including drug prices in listed countries. Retail prices of covered drugs under specified federal health programs (e.g., Medicare and Medicaid) may not exceed the established reference prices. Drugs must also be available at such prices to uninsured individuals and to individuals with private health insurance.

 Related & companion bills 1
  • HR 2829 Identical bill End Price Gouging for Medications Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 1323: End Price Gouging for Medications Act. 117th Congress. Open America. https://openamerica.io/bill/117-S-1323/
MLA
"S. 1323: End Price Gouging for Medications Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-1323/.
Bluebook (legal)
S. 1323, 117th Cong. (2026), https://openamerica.io/bill/117-S-1323/.
Markdown link
[S. 1323: End Price Gouging for Medications Act](https://openamerica.io/bill/117-S-1323/)
Report a problem